algostase mono 1 g tabl.
laboratoires s.m.b. sa-nv - paracetamol 1000 mg - tablet - 1 g - paracetamol 1000 mg - paracetamol
prostaserene 320 mg hard caps.
therabel pharma sa-nv - serenoa repens (bartram) small, fruit, lipophilic extract 320 mg - capsule, hard - 320 mg - sabal serrulata (serenoa repens), lipophilic extract by co2 320 mg - sabalis serrulatae fructus
algostase 500 mg - 50 mg efferv. tabl.
laboratoires s.m.b. sa-nv - caffeine 50 mg; povidone 20,83 mg; paracetamol 500 mg - effervescent tablet - paracetamol, combinations excl. psycholeptics
algostase mono 1 g tabl.
laboratoires s.m.b. sa-nv - paracetamol 1000 mg - tablet - paracetamol
algostase mono 500 mg tabl.
laboratoires s.m.b. sa-nv - paracetamol 500 mg - tablet - paracetamol
hexakapron injection
teva israel ltd - tranexamic acid - solution for injection - tranexamic acid 500 mg / 5 ml - tranexamic acid - tranexamic acid - prevention and treatment of haemorrhages due to general or local fibrinolysis in adults and children from one year.specific indications include:- haemorrhage caused by general or local fibrinolysis such as: * menorrhagia and metrorrhagia * gastrointestinal bleeding * haemorrhagic urinary disorders, further to prostate surgery or surgical procedures affecting the urinary tract- ear nose throat surgery (adenoidectomy, tonsillectomy, dental extractions)- gynaecological surgery or disorders of obstetric origin- thoracic and abdominal surgery and other major surgical intervention such as cardiovascular surgery- management of haemorrhage due to the administration of a fibrinolytic agent.